IMT504 is a non-CpG oligodeoxynucleotide and an immune-modulating oligonucleotide, showing potential as a rabies vaccine. It has demonstrated vaccine efficacy in animal models of chronic lymphocytic leukemia, tissue regeneration, and sepsis.
CAS Nummer:
[1075758-80-3]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
